These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7521414

  • 1. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy].
    Osada T, Iwabuchi S, Takatori M, Murayama M, Iino S.
    Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414
    [Abstract] [Full Text] [Related]

  • 2. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M.
    J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
    [Abstract] [Full Text] [Related]

  • 3. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA, Bailly F, Si-Ahmed SN, Chevallier P, Sepetjan M, Colucci G, Trépo C.
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatitis C virus RNA levels determined by branched DNA probe assay correlated with levels assessed using competitive PCR.
    Hayashi J, Yoshimura E, Kishihara Y, Yamaji K, Etoh Y, Ikematsu H, Kashiwagi S.
    Am J Gastroenterol; 1996 Feb; 91(2):314-8. PubMed ID: 8607499
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
    Hige S.
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S, Yokosuka O, Imazeki F, Saisho H, Mizuno C.
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [Abstract] [Full Text] [Related]

  • 13. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
    Nagayama R, Shoji S, Miyake K.
    Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C].
    Osada T, Iwabuchi S, Iino S.
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):287-93. PubMed ID: 7563727
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.